Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2014
Title: Giovanni Sorba: Innovator in Phosphatidylinositol 3-Kinase Inhibition
Introduction
Giovanni Sorba is a notable inventor based in San Giusto Canavese, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit phosphatidylinositol 3-kinases (PI3Ks). His work has implications for treating various pathological conditions associated with alterations in PI3K activity.
Latest Patents
Giovanni Sorba holds a patent for "Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases." This patent describes compounds of Formula (I) that are capable of inhibiting kinase activity, specifically targeting phosphatidylinositol 3-kinases. The disclosure also highlights the potential use of these compounds in treating conditions linked to PI3K activity alterations.
Career Highlights
Throughout his career, Giovanni Sorba has been associated with prestigious institutions such as the Università Degli Studi Di Torino and the Università Degli Studi Del Piemonte Orientale "Amedeo Avogadro." His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Giovanni has collaborated with esteemed colleagues, including Gian Cesare Tron and Ubaldina Galli. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Giovanni Sorba's contributions to the field of biochemistry, particularly through his patent on PI3K inhibitors, demonstrate his commitment to advancing medical science. His collaborations and career highlights further underscore his role as an influential inventor in this domain.